Renaissance Technologies (RenTech)'s MD Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.53 M shares of Pediatrix Medical Group, Inc. (MD) worth $32.78 M, representing 0.05% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in MD, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 453,000 shares. Largest reduction occurred in Q1 2020, reducing 413,259 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Pediatrix Medical Group (MD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pediatrix Medical Group (MD) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +174,600 | Add 12.86% | 1.53 M | $21.39 |
| Q4 2025 | +51,700 | Add 3.96% | 1.36 M | $21.39 |
| Q3 2025 | +102,100 | Add 8.48% | 1.31 M | $16.75 |
| Q2 2025 | -17,100 | Reduce 1.40% | 1.2 M | $14.35 |
| Q1 2025 | +382,200 | Add 45.57% | 1.22 M | $14.49 |
| Q4 2024 | +453,000 | Add 117.42% | 838,800 | $13.12 |
| Q3 2024 | -28,200 | Reduce 6.81% | 385,800 | $11.59 |
| Q2 2024 | -20,300 | Reduce 4.67% | 414,000 | $7.55 |
| Q1 2024 | +77,000 | Add 21.55% | 434,300 | $10.03 |
| Q4 2023 | +309,100 | Add 641.29% | 357,300 | $9.30 |
| Q3 2023 | -5,100 | Reduce 9.57% | 48,200 | $12.72 |
| Q2 2023 | -55,900 | Reduce 51.19% | 53,300 | $0.01 |
| Q1 2023 | +109,200 | New Buy | 109,200 | $0.01 |
| Q3 2022 | -140,200 | Sold Out | 0 | $0.00 |
| Q2 2022 | -185,600 | Reduce 56.97% | 140,200 | $21.01 |
| Q1 2022 | +205,600 | Add 171.05% | 325,800 | $23.48 |
| Q4 2021 | -98,500 | Reduce 45.04% | 120,200 | $27.21 |
| Q3 2021 | -92,600 | Reduce 29.75% | 218,700 | $28.43 |
| Q2 2021 | +311,300 | New Buy | 311,300 | $30.15 |
| Q1 2021 | -206,400 | Sold Out | 0 | $0.00 |
| Q4 2020 | -209,100 | Reduce 50.32% | 206,400 | $24.54 |
| Q3 2020 | +61,600 | Add 17.41% | 415,500 | $16.28 |
| Q2 2020 | -129,511 | Reduce 26.79% | 353,900 | $17.10 |
| Q1 2020 | -413,259 | Reduce 46.09% | 483,411 | $11.64 |
| Q4 2019 | +171,370 | Add 23.63% | 896,670 | $27.79 |
| Q3 2019 | -31,100 | Reduce 4.11% | 725,300 | $22.62 |
| Q2 2019 | +49,700 | Add 7.03% | 756,400 | $25.23 |
| Q1 2019 | +214,500 | Add 43.58% | 706,700 | $27.17 |
| Q4 2018 | -85,000 | Reduce 14.73% | 492,200 | $33.00 |
| Q3 2018 | +408,577 | Add 242.30% | 577,200 | $46.66 |
| Q2 2018 | +168,623 | New Buy | 168,623 | $43.28 |
| Q3 2016 | -252,200 | Sold Out | 0 | $0.00 |
| Q2 2016 | -189,400 | Reduce 42.89% | 252,200 | $72.43 |
| Q1 2016 | +441,600 | New Buy | 441,600 | $64.62 |
| Q3 2015 | -371,000 | Sold Out | 0 | $0.00 |
| Q2 2015 | -89,300 | Reduce 19.40% | 371,000 | $74.11 |
| Q1 2015 | +107,000 | Add 30.29% | 460,300 | $72.51 |
| Q4 2014 | -46,500 | Reduce 11.63% | 353,300 | $66.11 |
| Q3 2014 | +370,100 | Add 1246.13% | 399,800 | $54.82 |
| Q2 2014 | +24,700 | Add 494.00% | 29,700 | $58.15 |
| Q1 2014 | +5,000 | New Buy | 5,000 | $62.00 |
Renaissance Technologies (RenTech)'s Pediatrix Medical Group Investment FAQs
Renaissance Technologies (RenTech) first purchased Pediatrix Medical Group, Inc. (MD) in Q1 2014, acquiring 5,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Pediatrix Medical Group, Inc. (MD) for 41 quarters since Q1 2014.
Renaissance Technologies (RenTech)'s largest addition to Pediatrix Medical Group, Inc. (MD) was in Q4 2024, adding 838,800 shares worth $11.01 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,532,300 shares of Pediatrix Medical Group, Inc. (MD), valued at approximately $32.78 M.
As of the Q1 2026 filing, Pediatrix Medical Group, Inc. (MD) represents approximately 0.05% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Pediatrix Medical Group, Inc. (MD) was 1,532,300 shares, as reported at the end of Q1 2026.